Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Lymphoma
Sort By
Newest First
1 / 1
1 / 1
FDA Approval
FDA Approves Treatment for Two Rare Types of Non-Hodgkin Lymphoma
U.S. Food & Drug Administration
PR-M08-18-NI-111
Aug 29, 2018
Clinical Trials
Celgene Announces Phase III ‘AUGMENT’ Study of REVLIMID® in Combination with Rituximab (R2)
Celgene Corporation
PR-M07-18-NI-085
Jul 25, 2018
